Gene Symbol | SDC1 |
Entrez ID | 6382 |
Uniprot ID | P18827 |
Description | syndecan 1 |
Chromosomal Location | chr2: 20,200,797-20,225,433 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0001523 |
retinoid metabolic process |
The chemical reactions and pathways involving retinoids, any member of a class of isoprenoids that contain or are derived from four prenyl groups linked head-to-tail. Retinoids include retinol and retinal and structurally similar natural derivatives or synthetic compounds, but need not have vitamin A activity. |
TAS |
BP |
GO:0001657 |
ureteric bud development |
The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure. |
IEA |
BP |
GO:0006024 |
glycosaminoglycan biosynthetic process |
The chemical reactions and pathways resulting in the formation of glycosaminoglycans, any of a group of polysaccharides that contain amino sugars. |
TAS |
BP |
GO:0006027 |
glycosaminoglycan catabolic process |
The chemical reactions and pathways resulting in the breakdown of glycosaminoglycans, any one of a group of polysaccharides that contain amino sugars. |
TAS |
BP |
GO:0006954 |
inflammatory response |
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
IEA |
BP |
GO:0009636 |
response to toxic substance |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus. |
IEA |
BP |
GO:0016477 |
cell migration |
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms. |
IBA |
BP |
GO:0030203 |
glycosaminoglycan metabolic process |
The chemical reactions and pathways involving glycosaminoglycans, any one of a group of polysaccharides that contain amino sugars. Formerly known as mucopolysaccharides, they include hyaluronic acid and chondroitin, which provide lubrication in joints and form part of the matrix of cartilage. The three-dimensional structure of these molecules enables them to trap water, which forms a gel and gives glycosaminoglycans their elastic properties. |
TAS |
BP |
GO:0042060 |
wound healing |
The series of events that restore integrity to a damaged tissue, following an injury. |
IEA |
BP |
GO:0042157 |
lipoprotein metabolic process |
The chemical reactions and pathways involving any conjugated, water-soluble protein in which the nonprotein group consists of a lipid or lipids. |
TAS |
BP |
GO:0042476 |
odontogenesis |
The process whose specific outcome is the progression of a tooth or teeth over time, from formation to the mature structure(s). A tooth is any hard bony, calcareous, or chitinous organ found in the mouth or pharynx of an animal and used in procuring or masticating food. |
IEA |
BP |
GO:0042542 |
response to hydrogen peroxide |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus. |
IEA |
BP |
GO:0048627 |
myoblast development |
The process whose specific outcome is the progression of the myoblast over time, from its formation to the mature structure. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers. |
ISS |
BP |
GO:0051384 |
response to glucocorticoid |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects. |
IEA |
BP |
GO:0051591 |
response to cAMP |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus. |
IEA |
BP |
GO:0051592 |
response to calcium ion |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus. |
IEA |
BP |
GO:0055002 |
striated muscle cell development |
The process whose specific outcome is the progression of a striated muscle cell over time, from its formation to the mature structure. Striated muscle cells contain fibers that are divided by transverse bands into striations, and cardiac and skeletal muscle are types of striated muscle. |
IEP |
BP |
GO:0060009 |
Sertoli cell development |
The process whose specific outcome is the progression of a Sertoli cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a Sertoli cell fate. |
IEA |
BP |
GO:0060070 |
canonical Wnt signaling pathway |
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes. |
IEA |
BP |
GO:1903543 |
positive regulation of exosomal secretion |
Any process that activates or increases the frequency, rate or extent of exosomal secretion. |
IMP |
BP |
GO:1903553 |
positive regulation of extracellular exosome assembly |
Any process that activates or increases the frequency, rate or extent of extracellular vesicular exosome assembly. |
IMP |
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
IDA |
CC |
GO:0005796 |
Golgi lumen |
The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks. |
TAS |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
TAS |
CC |
GO:0005887 |
integral component of plasma membrane |
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
TAS |
CC |
GO:0005925 |
focal adhesion |
Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. |
IDA |
CC |
GO:0009897 |
external side of plasma membrane |
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
IEA |
CC |
GO:0009986 |
cell surface |
The external part of the cell wall and/or plasma membrane. |
IDA |
CC |
GO:0043202 |
lysosomal lumen |
The volume enclosed within the lysosomal membrane. |
TAS |
CC |
GO:0043234 |
protein complex |
A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical. |
IEA |
CC |
GO:0070062 |
extracellular exosome |
A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
IDA |
MF |
GO:0001948 |
glycoprotein binding |
Interacting selectively and non-covalently with a glycoprotein, a protein that contains covalently bound glycose (monosaccharide) residues. These also include proteoglycans. |
IEA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0008022 |
protein C-terminus binding |
Interacting selectively and non-covalently with a protein C-terminus, the end of any peptide chain at which the 1-carboxy function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue. |
IPI |
Domain ID | Description |
---|---|
IPR001050 |
Syndecan |
IPR003585 |
Neurexin/syndecan/glycophorin C |
IPR027789 |
Syndecan/Neurexin domain |
IPR030479 |
Syndecan, conserved site |
IPR031190 |
Syndecan-1 |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04512 |
ECM-receptor interaction |
KEGG |
hsa04514 |
Cell adhesion molecules (CAMs) |
KEGG |
hsa05144 |
Malaria |
KEGG |
hsa05205 |
Proteoglycans in cancer |
KEGG |
hsa05418 |
Fluid shear stress and atherosclerosis |
KEGG |
Tissue | Cell Type |
---|---|
appendix |
glandular cells |
cervix, uterine |
squamous epithelial cells |
colon |
glandular cells |
duodenum |
glandular cells |
esophagus |
squamous epithelial cells |
gallbladder |
glandular cells |
kidney |
cells in tubules |
oral mucosa |
squamous epithelial cells |
placenta |
trophoblastic cells |
rectum |
glandular cells |
small intestine |
glandular cells |
tonsil |
squamous epithelial cells |
urinary bladder |
urothelial cells |
vagina |
squamous epithelial cells |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
ZNF593 |
51042 |
O00488 |
0.49 |
ELANE |
1991 |
P08246 |
0.52 |
APP |
351 |
P05067 |
0.56 |
EP300 |
2033 |
Q09472 |
0.63 |
MDK |
4192 |
P21741 |
0.63 |
SDC1 |
6382 |
P18827 |
0.69 |
HGF |
3082 |
P14210 |
0.75 |
CXCL8 |
3576 |
P10145 |
0.75 |
CTSG |
1511 |
P08311 |
0.85 |
PTN |
5764 |
P21246 |
0.86 |
AHCY |
191 |
P23526 |
0.49 |
PECAM1 |
5175 |
P16284 |
0.49 |
IGFBP7 |
3490 |
Q16270 |
0.52 |
PDCD6IP |
10015 |
Q8WUM4 |
0.52 |
CD63 |
967 |
P08962 |
0.56 |
PTEN |
5728 |
P60484 |
0.56 |
FGF2 |
2247 |
P09038 |
0.58 |
SDC2 |
6383 |
P34741 |
0.58 |
SDC3 |
9672 |
O75056 |
0.58 |
CD9 |
928 |
P21926 |
0.63 |
MNDA |
4332 |
P41218 |
0.63 |
BAG3 |
9531 |
O95817 |
0.63 |
PYHIN1 |
149628 |
Q6K0P9 |
0.63 |
MMP14 |
4323 |
P50281 |
0.65 |
SDCBP |
6386 |
O00560 |
0.73 |
CASK |
8573 |
O14936 |
0.78 |
LACRT |
90070 |
Q9GZZ8 |
0.79 |
CCL5 |
6352 |
P13501 |
0.83 |